There are years of results. Owcp has been going at it since 2014. With that said, Big Pharma has 3 full years of data to scope out. The next results will just be safety results. Owcp should have had a pretty good idea going into the safety study whether the products were safe or not. So say Owcp knew they would obtain positive safety results....they're not going to wait to verify what they already know to start talking with companies and negotiating deals. The objective is to start the flow of revenue asap. They have been negotiating deals IMO for months now.

What I believe is holding up the show is IP protection. Without fully protected patents, nothing is for certain and owcp needs to remain tight lipped to keep their inventions confidential. We need to protect our IP before we publicly display study information like protocols and results.

I think owcp is going to the conference because there is always room for more money from investors. This will give owcp good exposure with new key management changes adding Hirsch to the board. And owcp has several inventions. One partner may only have interest in certain inventions, leaving room for possibly multiple partners.

I'm banking on news prior to the conference, something significant this time. A game changer. Lets go owcp!!